Alice Blue Home
URL copied to clipboard

Trending News

Penny stock hits 5% upper circuit after declaring 1:1 bonus issue and 1:10 stock split

Prominent pharmaceutical firm plans a 1:10 stock split and up to 1:1 bonus issue, enhancing share liquidity without altering shareholder ownership or value.

Introduction

Leading pharmaceutical company plans to propose a 1:10 stock split and up to 1:1 bonus share issue, aiming to increase share liquidity while maintaining shareholder ownership and overall value.

Alice Blue Image

Also Read: Chemical stock in focus after company announces 1:2 stock split 3:1 bonus issue

Share price movement of Welcure Drugs

On August 11, 2025, Welcure Drugs & Pharmaceuticals Ltd opened at ₹10.59, up 4.96% from its previous close of ₹10.09. The stock reached a high of ₹10.59 and a low of ₹10.58. By 4:01 PM, it traded at ₹10.59, with a market cap of ₹119.15 crore.

Welcure Board to Consider Stock Split, Bonus

Welcure Drugs & Pharmaceuticals Limited announced a Board meeting on August 22, 2025. The Board will consider a 1:10 stock split and a bonus issue up to 1:1, subject to approvals.

If approved, shareholders will receive one bonus share for every share held. The stock split will convert one share into ten shares. Both actions will increase the total shares held by shareholders.

Recent news on Welcure Drugs

As of June 18, 2025, Welcure Drugs & Pharmaceuticals Ltd secured a ₹517 crore mandate with Thailand’s Fortune Sagar Impex for third-party sourcing and procurement of multiple finished-dosage pharmaceutical SKUs.

Stock performance of Welcure Drugs for Period of 1 week, 6 months, and 1 year

Welcure Drugs & Pharmaceuticals Ltd delivered a 4.78% return over the past week, a 4.99% gain in the past six months, and a 37.6% increase over the past year.

Alice Blue Image

Also Read: Q1 Results: Stock hits 20% upper circuit after its net profit grows 296% YoY

Shareholding pattern of Welcure Drugs

ParticularsJun 2025Mar 2025Dec 2024
Promoter0%0%0%
FII0%0%0%
DII0%0%0%
Public100.00%100.00%100%

About Welcure Drugs

Welcure Drugs & Pharmaceuticals Limited (BSE: 524661) is a debt-free Indian healthcare company specializing in compliant, fee-based procurement and export sourcing of pharmaceutical and allied products, committed to transparency and strong corporate governance.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs

Q: Why is Welcure Drugs & Pharmaceuticals Limited’s share price going up today?
A: The share price increased due to positive market momentum and recent corporate announcements.

Q: What does Welcure Drugs & Pharmaceuticals Limited specialize in?
A: It specializes in compliant, fee-based procurement and export sourcing of pharmaceutical and allied products.

Q: What is the 52-week high and low of Welcure stock?
A: The 52-week high is ₹15.89, and the 52-week low is ₹6.40.

Submit the form, and get to know how you scored!!!

Gainers & Losers

Read More News

*T&C apply